[在蛋白质S缺乏症中具有临床异质性的PROSI突变:一例病例报告]
Xin-Yu Wei1, Juan Wang1, Bang-Yun Tan2
1First Clinical Medical College of Lanzhou University,Lanzhou 730000,China.
概括
这项研究确定了PROS1基因中的新突变,c.292 G>T,与遗传性蛋白S缺乏有关. 这一发现有助于了解静脉血栓栓塞的遗传风险因素.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 减少蛋白S活性是静脉血栓塞栓症 (VTE) 的重要危险因素.
- 遗传性蛋白S缺乏症是一种自体主导性疾病,源于PROS1基因的突变.
- 识别新的突变对于理解VTE病原和遗传咨询至关重要.
研究的目的:
- 报告与遗传性蛋白S缺乏相关的PROS1基因中新发现的突变.
- 调查发现的PROS1基因突变的起源和国际新奇性.
- 为影响VTE风险的遗传因素的知识基础做出贡献.
主要方法:
- 用基因测序来识别PROS1基因中的突变.
- 在该患者身上发现了一种特定的突变,即3号外显子中的c.292 G>T.
- 进行了基因分析和数据库/文献搜索,以评估新奇性.
主要成果:
- 一个新的突变,c.292 G>T在PROS1基因的第3个外显子中,在一个女性患者中被确定.
- 这种突变很可能是从病人的母亲遗传的.
- 国际数据库和文献搜索证实了这种以前未报告的突变.
结论:
- 在PROS1基因中发现的c.292 G>T突变代表了遗传性S蛋白缺乏症的新原因.
- 这一发现扩大了已知与VTE风险相关的PROS1突变的范围.
- 进一步的研究可能会阐明这种突变对蛋白S功能和VTE发展的具体影响.
相关概念视频
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
Mutations
83.6K
Overview
83.6K
Translation
142.3K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.3K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K


